Volodymyr Blagodatnyi

According to our database, Volodymyr Blagodatnyi authored at least 4 papers between 2016 and 2021.

Collaborative distances:

• Dijkstra number of six.
• Erdős number of five.

2021

1, 3-Oxazole derivatives of cytisine as potential inhibitors of glutathione reductase of <i>Candida spp.</i>: QSAR modeling, docking analysis and experimental study of new anti-Candida agents.

Larysa Metelytsia, Maria M. Trush, Vasyl V. Kovalishyn, Diana M. Hodyna, Maryna V. Kachaeva, Volodymyr Brovarets, Stepan Pilyo, Volodymyr V. Sukhoveev, Serhii A. Tsyhankov, Volodymyr Blagodatnyi, Ivan Semenyuta

Comput. Biol. Chem., 2021

2020

Design of (quinolin-4-ylthio)carboxylic acids as new <i>Escherichia coli</i> DNA gyrase B inhibitors: machine learning studies, molecular docking, synthesis and biological testing.

Larysa Metelytsia, Diana M. Hodyna, Inga Dobrodub, Ivan Semenyuta, Mikhail Zavhorodnii, Volodymyr Blagodatnyi, Vasyl V. Kovalishyn, Oleksandr Brazhko

Comput. Biol. Chem., 2020

2018

Imidazolium ionic liquids as effective antiseptics and disinfectants against drug resistant <i>S. aureus</i>: <i>In silico</i> and <i>in vitro</i> studies.

Diana M. Hodyna, Vasyl V. Kovalishyn, Ivan Semenyuta, Volodymyr Blagodatnyi, Sergiy Rogalsky, Larysa Metelytsia

Comput. Biol. Chem., 2018

2016

1, 3-Oxazole derivatives as potential anticancer agents: Computer modeling and experimental study.

Ivan Semenyuta, Vasyl V. Kovalishyn, Vsevolod Tanchuk, Stepan Pilyo, Vladimir Zyabrev, Volodymyr Blagodatnyy, Olena Trokhimenko, Volodymyr Brovarets, Larysa Metelytsia

Comput. Biol. Chem., 2016